Inhibition of XBP1 in an embryonic fibroblast cell line and in fibrosarcoma cells had no effect on the secretion of pro-angiogeneic growth factors, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). The gene discussed is FGF2; the disease is fibrosarcoma.